$JNCE: Jounce Therapeutics Presents Reverse Translational, Biomarker …

Date: Saturday, November 10th, 2018

Stock(s) mentioned:

Source: Benzinga (https://www.benzinga.com)

Summary: 10, 2018 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc. (NASDAQ:JNCE), a clinical-stage company focused on the discovery and development of novel …

Full article address: https://www.benzinga.com/pressreleases/18/11/g12675655/jounce-therapeutics-presents-reverse-translational-biomarker-and-precl

Related News:

$JNCE $ETX: Hedge Funds Are Crazy About Jounce Therapeutics, Inc. (JNCE)

$JNCE: Jounce Therapeutics, Inc. (JNCE) CEO Richard Murray on Q3 2018 …

$JNCE: Jounce Therapeutics to Present Two Posters from the JTX-2011 …

$JNCE: Jounce Therapeutics Founder Dr. James P. Allison Jointly Awarded …

$JNCE: Jounce Therapeutics to Present at the 2018 Cantor Global …

$JNCE: Jounce Therapeutics to Present Nonclinical Translational Data at …

$JNCE $SGMO $GILD $PFE: Biotech Fire Sale: 2 Top Stocks to Buy Next Week

Latest News:

$SPX: Outside the Box: Sorry Bernie, stock buybacks aren’t to blame for America’s rising income inequality

$NFLX $DIS: What The 2019 Oscars Mean For Netflix Investors

$IMDZ $MRK: 65 Biggest Movers From Yesterday

$EXTR: Mobile World Congress 2019 I Cision Roundup

$APC: Anadarko Appraising Wyoming’s Emerging Powder Oil Play

$MN: Visiongain Report Offers Transformative Insights on the $367m Tire …

$BZUN: Baozun Inc. to Announce Fourth Quarter and Fiscal Year 2018 …

$JWN: NerdWallet: Banking apps use behavioral economics to change our money habits

$GOOG $AAPL: Credit.com: Are ATM fees eating away your bank account?

$AN $ZG: 10 Stocks To Watch For February 22, 2019

$BIDU: Baidu, Inc. (BIDU) CEO Robin Li on Q4 2018 Results – Earnings Call …